Cite
Acute Coronary Syndromes, Gastrointestinal Protection, and Recommendations Regarding Concomitant Administration of Proton-Pump Inhibitors (Omeprazol/Esomeprazole) and Clopidogrel.
MLA
Lozano, Iñigo, et al. “Acute Coronary Syndromes, Gastrointestinal Protection, and Recommendations Regarding Concomitant Administration of Proton-Pump Inhibitors (Omeprazol/Esomeprazole) and Clopidogrel.” American Journal of Cardiology, vol. 117, no. 3, Feb. 2016, pp. 366–68. EBSCOhost, https://doi.org/10.1016/j.amjcard.2015.11.007.
APA
Lozano, I., Sanchez-Insa, E., de Leiras, S. R., Carrillo, P., Ruiz-Quevedo, V., Pinar, E., Gopar-Gopar, S., Bayon, J., Mañas, P., Lasa, G., CruzGonzalez, I., Hernandez, F., Fernandez-Portales, J., Fernandez-Fernandez, J., Pérez-Serradilla, A., de la Torre Hernandez, J. M., & Gomez-Jaume, A. (2016). Acute Coronary Syndromes, Gastrointestinal Protection, and Recommendations Regarding Concomitant Administration of Proton-Pump Inhibitors (Omeprazol/Esomeprazole) and Clopidogrel. American Journal of Cardiology, 117(3), 366–368. https://doi.org/10.1016/j.amjcard.2015.11.007
Chicago
Lozano, Iñigo, Esther Sanchez-Insa, Sergio Rodríguez de Leiras, Pilar Carrillo, Valeriano Ruiz-Quevedo, Eduardo Pinar, Silvia Gopar-Gopar, et al. 2016. “Acute Coronary Syndromes, Gastrointestinal Protection, and Recommendations Regarding Concomitant Administration of Proton-Pump Inhibitors (Omeprazol/Esomeprazole) and Clopidogrel.” American Journal of Cardiology 117 (3): 366–68. doi:10.1016/j.amjcard.2015.11.007.